Mannkind (MNKD) EBITDA (2010 - 2026)
Mannkind (MNKD) reported EBITDA of -$1.7 million for Q1 2026, down 107.48% year-over-year from $22.3 million in Q1 2025, and up 78.31% quarter-over-quarter from -$7.7 million in Q4 2025.
Mannkind (MNKD) EBITDA (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of EBITDA data on file, last reported at -$1.7 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$1.7 million, down 107.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.8 million (down 81.01% YoY), and the FY2025 annual result was $38.8 million, down 46.55% from the prior year.
- EBITDA rose to -$1.7 million in Q1 2026 per MNKD's latest filing, from -$7.7 million in the prior quarter.
- Over five years, EBITDA peaked at $26.5 million in Q4 2024 and troughed at -$21.3 million in Q1 2022.
- A 5-year average of $3.2 million and a median of $5.1 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2022 and 2024: EBITDA plunged 243.34% in 2022, then jumped 865.14% in 2024.
- A 5-year view of EBITDA shows it stood at -$12.8 million in 2022, then soared by 161.44% to $7.9 million in 2023, then surged by 237.17% to $26.5 million in 2024, then slumped by 129.01% to -$7.7 million in 2025, then soared by 78.31% to -$1.7 million in 2026.
- Business Quant data shows MNKD's EBITDA at -$1.7 million in Q1 2026, -$7.7 million in Q4 2025, and $18.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -1.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.67 Mn |
| Dec 31, 2025 | -7.69 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 22.29 Mn |
| Dec 31, 2024 | 26.50 Mn |
| Sep 30, 2024 | 12.76 Mn |
| Jun 30, 2024 | 16.61 Mn |
| Mar 31, 2024 | 16.72 Mn |
| Dec 31, 2023 | 7.86 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | -6.00 Mn |
| Dec 31, 2022 | -12.79 Mn |
| Sep 30, 2022 | -9.61 Mn |
| Jun 30, 2022 | -20.45 Mn |
| Mar 31, 2022 | -21.26 Mn |
| Dec 31, 2021 | -23.97 Mn |
| Sep 30, 2021 | -6.59 Mn |
| Jun 30, 2021 | -10.27 Mn |